Cover image of the article: Interpretation of Diagnostic Tests: Likelihood Ratio vs. Predictive Value

Image Credit:Inn J Pediatr

Interpretation of Diagnostic Tests: Likelihood Ratio vs. Predictive Value

Authors

Iraj Sedighi1,*
*Corresponding Author: Email: sedighi@umsha.ac.ir

Innovative Journal of Pediatrics:Vol. 23, issue 6; 717-717
Published online:Dec 04, 2013
Article type:Letter
Received:Mar 06, 2013
Accepted:Sep 25, 2013
How to Cite:Sedighi I. Interpretation of Diagnostic Tests: Likelihood Ratio vs. Predictive Value. Inn J Pediatr. 2013;23(6):. doi:

Abstract

Keywords1

Fulltext

We read with interest the Iranikhah et al’s article entitled “Stool Antigen Tests for the Detection of Helicobacter Pylori in Children” in the second issue of 2013 of Iran J Pediatr[1].
The authors have well reported an interesting investigation about the detection of bacterial antigens in stool for diagnosis of Helicobacter pylori in children. Also they appropriately used endoscopy and biopsy as a gold standard test for validation of the H. pylori infection and statistical indices are calculated accordingly. In the study, sensitivity, specificity, positive and negative likelihood ratios for H. pylori stool antigen was reported to be 85%, 93%, 89.7%, and 90% respectively, while 89.7%, and 90% are not likelihood ratios, they are positive and negative predictive values.
There are some notices which should be considered before using these indices.
The studies which mean to evaluate diagnostic tests or methods (as above mentioned Iranikhah et al’s article) usually represent the basic characteristics of tests such as sensitivity specificity, predictive value  and likelihood ratios to quantify diagnostic accuracy.
Two important measures of test performance are positive predictive value (PPV), the proportion of patients with positive test who actually have the disease, and negative predictive value (NPV), the proportion of patients with negative test who are actually free of the disease. These measures are usually represented as percentages.
Although clinicians are well familiar with predictive values, these measures are not invariant characteristics of the tests and significantly depend on the prevalence of the disease in the population tested. In order to solve this problem, the other measure can be used as Likelihood Ratio (LR) which is independent of prevalence[3,4].
LR is one of the most clinically useful measures. LR shows how much more likely someone is to get a positive test if he/she has the disease, compared with a person without disease. Positive LR is usually a number greater than one and the negative LR ratio usually is smaller than one.
Although LR is very useful and some authors have proposed simple methods to use this criterion, there are several limitations to using it in clinical practice. To use this measure a nomogram should be employed or pretest probabilities should be converted into Odds, then multiplied by LR, then converted back into post test  probability (Post-test odds = pre-test odds* LR)[5,6].
Based on the results of the above mentioned article, and calculating the likelihood ratios [LR+= sensitivity/(1-specificity)][LR-=(1-sensitivity)/ specificity] the following results are achieved:
LR+=[0.85/1-0.93=12.1] and LR-=[1-0.85/0.93= 0.16], this result indicates that positive H. pylori stool antigen test significantly increases the probability of H. pylori infection and negative H. pylori stool antigen test significantly decreases the probability of infection. Although these results indicate that the study is very admirable, the figures described in the article as the positive and negative likelihood ratio really are positive and negative predictive values which have a completely different meaning.
The quality of this manuscript was greatly enhanced by the gracious assistance of Parinaz Sedighi who sacrificed her time for critical discussions.

References

  • 1.
    References are available on the PDF.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

14
Jul
2018
Calculating Sensitivity, Specificity and Predictive Values for Medical Diagnostic Tests

Calculating Sensitivity, Specificity and Predictive Values for Medical Diagnostic Tests

Kareem Hatam Nahavandi

Hatam Nahavandi K. Calculating Sensitivity, Specificity and Predictive Values for Medical Diagnostic Tests. Gene Cell Tissue. 2018;5(2):e80270. doi: https://doi.org/10.5812/gct.80270

15
Feb
2005
Analyzing receiver operating characteristic curves to compare medical diagnostic tests

Analyzing receiver operating characteristic curves to compare medical diagnostic tests

SadatHashemi SadatHashemi,
Behroz Kavehei,
Raheb Ghorbani

SadatHashemi S, Kavehei B, Ghorbani R. Analyzing receiver operating characteristic curves to compare medical diagnostic tests. koomesh. 2005;6(2):e152046. doi:

30
Jan
2025
The Free Thyroxine-to-Thyroid Stimulating Hormone Ratio: A Potential Diagnostic Marker for Graves’ Disease

The Free Thyroxine-to-Thyroid Stimulating Hormone Ratio: A Potential Diagnostic Marker for Graves’ Disease

Norashidah Binti Rahmat,
Tuan Salwani Tuan Ismail,
Mohd Zakwan bin Md Muslim,
Wan Mohd Saifuhisam bin Wan Zain,
Adlin Zafrulan bin Zakaria,
Mohd Yusran bin Yusoff

Binti Rahmat N, Tuan Ismail TS, bin Md Muslim MZ, bin Wan Zain WMS, bin Zakaria AZ, et al. The Free Thyroxine-to-Thyroid Stimulating Hormone Ratio: A Potential Diagnostic Marker for Graves’ Disease. Int J Endocrinol Metab. 2025;23(1):e158565. doi: https://doi.org/10.5812/ijem-158565

30
Jan
2008
Usefulness of Triple Test Score for Breast Lesions

Usefulness of Triple Test Score for Breast Lesions

M Mokri,
M. Guity,
S. Shariat Torbaghan,
A. Arab Kheradmand,
E. Arbabai,
M. Bagherzade
,et al.

Mokri M, Guity M, Shariat Torbaghan S, Arab Kheradmand A, Arbabai E, et al. Usefulness of Triple Test Score for Breast Lesions. Int J Cancer Manag. 2008;1(1):e80389. doi:

30
Dec
2003
What Is Your Diagnosis?

What Is Your Diagnosis?

M. R. Farrokhy

Farrokhy MR. What Is Your Diagnosis?. I J Radiol. 2003;1(3&4):e79298. doi:

More by these authors

Iraj SedighiPubMedScholar
Share
Cited by
Metrics